LIXT (Lixte Biotechnology) Wutah bathi resik saben saham ing taun iki

LIXT (Lixte Biotechnology, Inc.) - tandha merek perusahaan

EPS YoY volatility demonstrates that the development of Lixte Biotechnology (LIXT) is independent of market conditions, as the fight against cancer remains a priority for medicine. Stable management effectively manages the R&D budget, earning the trust of funds, while the indicator reached the level of 0.00. Production risks are eliminated by outsourcing small molecule synthesis to certified CDMO plants.

Wutah bathi saben saham ing taun lumaku: Lixte Biotechnology Holdings Inc. (LIXT) kanggo 04.07.2022 - 06.07.2026

Rincian metrik keuangan lan pasar Lixte Biotechnology (LIXT)

Ringkesan analisis perusahaan:LIXT Lixte Biotechnology Holdings Inc.
Produk mawa merek Lixte Biotechnology

Lixte Biotechnology investments in the development of innovative cancer inhibitors drive its net profit dynamics. This metric measures the percentage deviation of current earnings per share from the same period last year. A positive trend confirms the effectiveness of the R&D strategy and growth in market capitalization. Sharp spikes signal increased volatility risks. By analyzing the annual EPS change scale, an investor assesses the probability of the asset's future returns.

Pesaing wigati

Wutah bathi saben saham ing taun iki INCY|HCM (HUTCHMED Ltd) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Nuvation Corp (NUVB)|Wutah bathi saben saham ing taun lumaku Day One (DAWN)|MNPR - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Inhibrx Biosciences, Inc. INBX|I-Mab Biopharma Co., Ltd. - Wutah bathi saben saham ing taun lumaku|FENC - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Heron Therapeutics|NVCT: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Coherus BioSciences CHRS|Wutah bathi resik saben saham ing taun iki CRBP|Kacepetan wutah bathi saben saham ing taun lumaku Cardiff Oncology Corp CRDF|Wutah bathi resik saben saham ing taun iki BYSI (BeyondSpring Pharma)|BCAB (bioatla.com) - Tambahing bathi saben saham ing taun lumaku|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CLRB (cellectar.com)|BioLineRx - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku CANF (Can-Fite BioPharma Ltd)|APRE: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Kazia Therapeutics Limited (KZIA)|Wutah bathi saben saham ing taun lumaku Silexion Therapeutics Corp.|NCNA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CMRX|Wutah bathi ing taun lumaku Cyclacel Pharmaceuticals, Inc. (CYCC)|Wutah bathi saben saham ing taun lumaku G1 Therapeutics GTHX|KRON (Kronos Bio Corporation) - Dinamika bathi saben saham ing taun lumaku|KTRA: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku oncternal.com|Portage Biotech (PRTG) - Wutah bathi saben saham ing taun lumaku